Genetic & Genomic MedicinemedRxivPreprint
GLP1R Variants and Polygenic Risk Underlie Heterogeneous Response to GLP-1 Receptor Agonists in Type 2 Diabetes
Munichandra Babu Tirumalasetty, Vivian Hsing-Chun Wang, Mohammad Sarif Mohiuddin…·Qing Miao
This study identifies genetic and clinical factors influencing glycemic response to GLP-1 receptor agonists in type 2 diabetes, showing that polygenic risk and GLP1R variants are associated with response variability.
DOI 10.64898/2026.07.29.26359248